company background image
BIOT logo

Biotage Informe acción OM:BIOT

Último precio

kr168.00

Capitalización de mercado

kr13.4b

7D

2.0%

1Y

10.5%

Actualizada

02 May, 2024

Datos

Finanzas de la empresa +

Biotage AB (publ)

Informe acción OM:BIOT

Capitalización de mercado: kr13.4b

Resumen de acción BIOT

Biotage AB (publ) ofrece soluciones y productos en las áreas de descubrimiento y desarrollo de fármacos, pruebas analíticas y pruebas de agua y medio ambiente.

Acerca de la empresa

BIOT fundamental analysis
Snowflake Score
Valuation3/6
Future Growth3/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Recompensas

Cotiza un 49.8% por debajo de nuestra estimación de su valor justo
Se prevé un crecimiento anual de los beneficios de 18.31%

Análisis de riesgos

Los accionistas han sido diluidos en el último año

Competidores de Biotage AB (publ)

AddLife

OM:ALIF B

kr12.5b

MedCap

OM:MCAP

kr6.4b

Genovis AB (publ.)

OM:GENO

kr1.8b

Magle Chemoswed Holding

OM:MAGLE

kr326.2m

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for Biotage
Historical stock prices
Current Share Pricekr168.00
52 Week Highkr187.10
52 Week Lowkr83.05
Beta0.80
1 Month Change-5.62%
3 Month Change15.07%
1 Year Change10.53%
3 Year Change-8.70%
5 Year Change37.14%
Change since IPO64.71%

Noticias y actualizaciones recientes

Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Apr 28
Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Apr 17
Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Apr 08
Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Recent updates

Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Apr 28
Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates

Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Apr 17
Biotage's (STO:BIOT) Dividend Will Be SEK1.60

Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Apr 08
Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Apr 03
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Mar 04
Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60

Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Feb 22
Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)

Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Feb 21
Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%

Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Feb 18
Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next

Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Feb 08
Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet

Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

Jan 07
Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)

At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Dec 08
At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?

Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Oct 27
Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Jul 12
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Jun 08
An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued

Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

May 24
Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 05
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Mar 12
These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely

Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 21
Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?

Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Jan 06
Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?

Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Dec 03
Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly

Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Oct 27
Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?

Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Oct 07
Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)

Biotage (STO:BIOT) Could Easily Take On More Debt

Sep 03
Biotage (STO:BIOT) Could Easily Take On More Debt

Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

Jul 10
Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jun 25
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

May 28
Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Apr 23
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Mar 29
Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year

Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Mar 14
Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Feb 28
Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?

Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

Feb 13
Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's

A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Jan 23
A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)

Is Biotage (STO:BIOT) A Risky Investment?

Dec 10
Is Biotage (STO:BIOT) A Risky Investment?

Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Nov 03
Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Biotage (STO:BIOT) Has A Rock Solid Balance Sheet

Aug 17
Biotage (STO:BIOT) Has A Rock Solid Balance Sheet

Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Jul 24
Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?

Rentabilidad de los accionistas

BIOTSE Life SciencesMercado SE
7D2.0%1.6%0.6%
1Y10.5%-5.0%11.1%

Rentabilidad vs. Industria: BIOT superó al sector Swedish Life Sciences , que obtuvo un rendimiento del -1.4% el año pasado.

Rentabilidad vs. Mercado: BIOT superó al mercado Swedish, que obtuvo un rendimiento del 7.8% el año pasado.

Volatilidad de los precios

Is BIOT's price volatile compared to industry and market?
BIOT volatility
BIOT Average Weekly Movement6.4%
Life Sciences Industry Average Movement6.6%
Market Average Movement6.2%
10% most volatile stocks in SE Market13.6%
10% least volatile stocks in SE Market3.6%

Precio estable de las acciones: BIOT no ha tenido una volatilidad de precios significativa en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de BIOT (6%) se ha mantenido estable durante el año pasado.

Acerca de la empresa

FundadaEmpleadosCEOPágina web
1969669Torben Jorgensenwww.biotage.com

Biotage AB (publ) ofrece soluciones y productos en las áreas de descubrimiento y desarrollo de fármacos, pruebas analíticas y pruebas medioambientales y de aguas. La empresa ofrece soluciones de síntesis orgánica y peptídica; productos de cromoterapia flash, evaporación y elaboración; sistemas flash; productos de preparación de muestras; soluciones de purificación de plásmidos; soluciones de síntesis de oligo; y eliminadores de metales y reactivos, así como accesorios y piezas de repuesto. También ofrece soluciones de preparación de muestras en las áreas clínica y bioanalítica, forense y toxicología, control del dopaje animal y humano, medio ambiente y alimentación y agricultura, así como consumibles y sistemas; soluciones de purificación de proteínas, incluida la purificación de anticuerpos y proteínas marcadas, sistemas de automatización y servicio de embalaje personalizado, así como columnas PhyTip de intercambio iónico, fase inversa, fase normal y filtración en gel.

Resumen de fundamentos de Biotage AB (publ)

¿Cómo se comparan los beneficios e ingresos de Biotage con su capitalización de mercado?
Estadísticas fundamentales de BIOT
Capitalización bursátilkr13.44b
Beneficios(TTM)kr236.00m
Ingresos (TTM)kr1.98b

57.0x

Ratio precio-beneficio (PE)

6.8x

Ratio precio-ventas (PS)

¿Está BIOT sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de BIOT
Ingresoskr1.98b
Coste de los ingresoskr749.00m
Beneficio brutokr1.23b
Otros gastoskr996.00m
Beneficioskr236.00m

Últimos beneficios comunicados

Mar 31, 2024

Próxima fecha de beneficios

Jul 16, 2024

Beneficios por acción (BPA)2.95
Margen bruto62.19%
Margen de beneficio neto11.91%
Ratio deuda/patrimonio3.9%

¿Cómo se ha desempeñado BIOT a largo plazo?

Ver rendimiento histórico y comparativa

Dividendos

1.0%

Rentabilidad actual por dividendo

52%

Ratio de pagos